ArticleMedicine international
Pulmonary angiosarcoma in an HIV-positive patient presenting with hemoptysis and multisystem involvement: Report of a rare case.
Article in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary angiosarcoma is a rare, aggressive malignancy often mimicking other lung cancers. The present study describes the case of a 36-year-old male patient with human immunodeficiency virus (HIV) on highly active antiretroviral therapy who developed severe hemoptysis and respiratory distress, initially attributing his symptoms to mold exposure. Imaging revealed bilateral pulmonary nodules surrounded by ground-glass (suggestive of hemorrhagic lesions), and a biopsy confirmed stage IV pulmonary angiosarcoma. Immunohistochemical staining yielded positive results for ERG, CD31, CD34 and CD117, and echocardiography identified a large tricuspid valve mass, suggesting metastatic disease. He was commenced on paclitaxel treatment, but switched to doxorubicin following an infusion reaction. His course was complicated by recurrent hemothorax and pericardial effusions, requiring thoracentesis, chest tube placement and pericardiocentesis. Due to disease progression and frequent readmissions, he ultimately opted for hospice care. The case described herein illustrates the diagnostic complexity of pulmonary angiosarcoma in the setting of HIV and highlights the poor prognosis associated with extensive pulmonary and cardiac involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.